Andere talen Bod Science Limited

Aandelen

BOD

AU0000181331

Beurs gesloten - Australian S.E. Andere beurzen 05:59:52 23-11-2023			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,024 ^AUD	-7,69%		-.--%	-.--%

2023	Bod Science Limited sluit leveringsovereenkomst met Green Farmers	CI
2023	Bod Science ontvangt AU$1,6 miljoen belastingteruggave voor R&D; aandelen stijgen 8%.	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bod Science Announces Delay in Appendix 4D Lodgement	25/03
BOD Science Signs Supply Agreement in Medicinal Cannabis with Green Farmers	13/12
Bod Science Limited Enters into Supply Agreement with Green Farmers	13/12
Bod Science Receives AU$1.6 Million R&D Tax Refund; Shares Rise 8%	22/11
Bod Expects to Receive Funds from Antah Soon	21/11
Bod Science Delays Settlement of Tranche 1 of AU$2.1 Million Placement	16/11
Bod Science Raises AU$2.1 Million Via Share Placement; Shares Fall 43%	08/11
Bod Science Limited announced that it expects to receive AUD 2.05 million in funding	08/11
Australian Shares Retreat as Monthly CPI Indicator Rises	27-09-23
Bod Science Validates Greater Bioavailability of Drug Delivery Technology; Shares Rally 12%	27-09-23
Bod Science Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30-08-23
Bod Science Limited Announces Change of Principal Place of Business	14-08-23
Bod Science Completes Acquisition of Drug Delivery Technology; Shares Up 3%	10-08-23
Bod Australia Limited completed the acquisition of Aqua Phase Ltd.	10-08-23
Bod Science Validates Bioavailability of Aqua Phase Technology	25-07-23
Bod Science Signs Letter of Intent to Sell Medical Cannabis Products in Malaysia	21-06-23
US Debt Ceiling Caution Dampens Appetite for Australian Equities	23-05-23
Bod Australia Secures Ethics Approval for Drug Delivery Study; Shares Jump 10%	23-05-23
Bod Science Limited Announces David Baker Assumes an Additional Advisory Role to Support Management to Progress A Number of Commercial Initiatives	24-04-23
BOD Science Completes Recruiting for Phase IIb Clinical Trial of CBD Product	04-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bod Science Limited

Aandelen

BOD

AU0000181331

Andere talen

Filters